In particular, Fakhrejahani and colleagues [105] first performed a pilot clinical study with a prototype PAI machine, in order to compare the distribution pattern of the Hb signal and the oxygen saturation level in primary malignant breast tumors and contralateral normal breasts as control. This evidence concerns the gene GSTM1 and breast cancer.